Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

#160; Operating as Actavis Pharma, the Company develops, manufactures and markets generic, branded generic, legacy brands and Over-the-Counter (OTC) products in more than 60 countries.  The Company is ranked in the top 3 in 12 global markets, the top 5 in 16 global markets, and in the top 10 in 33 global markets.   Actavis Pharma also develops and out-licenses generic pharmaceutical products outside the U.S. through its Medis third-party business, the world's largest generic pharmaceutical out-licensing business. Medis has more than 300 customers globally, and offers a broad portfolio of more than 200 products. 

Actavis Specialty Brands is the Company's global branded specialty pharmaceutical business, which develops and markets a portfolio of approximately 40 products principally in the United States and Canada that are focused in the Urology and Women's Health therapeutic categories.  Actavis Specialty Brands is committed to developing and marketing biosimilars products in Women's Health, Oncology and other therapeutic categories, and currently has a portfolio of 5 biosimilar products in development.  

Actavis Global Operations has more than 30 manufacturing and distribution facilities around the world, with a capacity of approximately 44 billion units annually.  Actavis Global Operations also includes Anda, Inc., the fourth-largest U.S. generic pharmaceutical product distributor in the United States.

For press release and other company information, visit Actavis' Web site at http://www.actavis.com.

Forward-Looking Statement Statements contained in this press release that refer to Actavis' estimated or anticipated future results or other non-historical facts are forward-looking statements that reflect Actavis' current perspective of existing trends and information as of the date of this release.  For instance, any statements in this press release concerning prospe
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)...  The number of retail health clinics in ... thanks to drug store chains, according to Kalorama Information.  ... downturn, retail clinic growth had been at a standstill, ... number of retail clinics reached nearly 1,600 according to ... Overview and 2014 Consumer Survey Results .  ...
(Date:10/30/2014)... 30, 2014 China Biologic Products, Inc. (NASDAQ: ... integrated plasma-based biopharmaceutical company in China ... third quarter 2014 financial results on Wednesday, November 5, ... Company,s management will hold a conference call at 7:30 ... is 8:30 p.m., Beijing Time on November 6, 2014, ...
(Date:10/30/2014)... , October 30, 2014 ... GG hilft beim Aufbau von Kuhmilchverträglichkeit     ... für Lebensmittelallergien bei Säuglingen und Kleinkindern. Der ... bei der Ernährung der Babys bzw. deren ... sich jedoch, dass sich bei einer beträchtlichen ...
Breaking Medicine Technology:Report: Drugstore Chains Drive Retail Clinic Growth 2Report: Drugstore Chains Drive Retail Clinic Growth 3China Biologic to Report Third Quarter 2014 Financial Results 2Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 2Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 3
... Inc. (Nasdaq: REGN ) today announced that ... the U.S. Food and Drug Administration (FDA) for VEGF ... age-related macular degeneration (wet AMD).  Under the Prescription Drug ... review time from submission to FDA action is ten ...
... 22, 2011 ResearchDx announced today the official ... CDO. Recent FDA initiatives, such ... Co-Development Concept Paper, have spurred biopharmaceutical companies, interest ... companion diagnostics. The traditional Contract Research Organization (CRO), ...
Cached Medicine Technology:Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration 2Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration 3Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration 4Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration 5Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration 6Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration 7ResearchDx Launches Contract Diagnostics Organization (CDO) 2
(Date:10/30/2014)... Cary, N.C. (PRWEB) October 30, 2014 ... consumer-driven health care, is increasing efforts to help people ... out-of-pocket expenses continue to increase for prescription drugs in ... provides valuable savings and resources to bridge the relationship ... , One of the biggest challenges people face today ...
(Date:10/30/2014)... October 30, 2014 Home Care Assistance ... provider of non-medical, in-home senior care, is weighing in ... brain health. , The study, performed by the University ... 60 and 78 over a week-long period and observed ... daily physical activity. By examining the structural soundness of ...
(Date:10/30/2014)... 30, 2014 REV'D Provision Co. announced ... available through a unique service called, The Feed ... empower the everyday athlete. The Feed has taken the ... created a system to pass that information on to ... is now available on The Feed!” says REV’D® marketing ...
(Date:10/30/2014)... -- When it comes to heart disease, a new study ... when they have symptoms that spell trouble. "The main ... a more severe or advanced stage of heart disease, there ... a Fulbright Scholar and research fellow at the Harvard School ... Heart and Stroke Foundation of Canada. In the study, ...
(Date:10/30/2014)... -- Eating a low-carb, high-fat diet could help control ... research. A review of five studies found ... on foods like bacon, eggs, heavy cream, butter, fish ... whose condition doesn,t improve with medication. "We need ... epilepsy whose seizures are not stopped by medications," study ...
Breaking Medicine News(10 mins):Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 3Health News:Nutrition Experts at TheFeed.com Get REV'D 2Health News:Nutrition Experts at TheFeed.com Get REV'D 3Health News:Women Often Ignore Signs of Heart Trouble 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3
... S.C., June 2 Companion Data Services, ... International Organization for,Standardization (ISO) 9001:2000 certification, the ... CDS provides information technology and data processing ... by the federal,Centers for Medicare & Medicaid ...
... Work, Discusses Abbott,s, Contributions to Access, Innovation, Science ... June 2 Abbott (NYSE: ABT ),today ... Work,",which is available online at http://www.abbott.com/citizenship . ... innovation, science,education and the environment., Named to ...
... problem of how many identical-sized spheres can be randomly ... A team of physicists at The City College ... solution that could have implications for everything from processing ... May 29 edition of "Nature," they demonstrate that random ...
... Ignoring scientific,evidence of harm, the Louisiana State ... by the House, will require fluoride chemicals be,added ... to reduce,tooth decay. (The Advocate, 5/29/08), However, ... by,the prestigious National Research Council (NRC) reveals that ...
... Way for Approval of Merger, CHICAGO, June ... connectivity and information solutions that,physicians use to improve ... Hart-Scott-Rodino (HSR) Antitrust Improvements Act of,1976, with respect ... 2008,between Allscripts and Misys Healthcare to form Allscripts-Misys ...
... 15% of their daily calories, study finds , , MONDAY, June ... more sugary beverages and fruit juices than ever before, a ... now take in up to 15 percent of their total ... confirms previous research and suggests consumption is rising. , It,s ...
Cached Medicine News:Health News:Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care 2Health News:Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care 3Health News:Louisiana May Mandate Fluoridation Despite Evidence of Harm 2Health News:Antitrust Waiting Period Expires on Allscripts-Misys Merger Agreement 2Health News:Kids Gulping Down More Sugary Beverages 2Health News:Kids Gulping Down More Sugary Beverages 3
... for sample processing consists of a clear ... applied, a chemical-resistant polypropylene lid, and a ... handling. The manifold is designed for consistent ... samples simultaneously. Loading, washing, and elution steps ...
Holder for QIAGEN 96-well plates, for use with QIAvac 96;...
Replacement gaskets for the Empore 96 Well Vacuum Manifold Assembly, insure a tight seal....
... with hydrophobic PTFE membranes,Millex filter units ... for the sterilizing filtration of gases, ... for sterilizing or clarifying organic solutions. ... units are available with different outlet ...
Medicine Products: